APO RESEARCH · REPORT
Dry Eye Drugs
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Product & engineering
Understand the product.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Selected research
Market Structure
Global Dry Eye Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.
Read the full market overview
In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.
This report provides an overview of the global Dry Eye Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Dry Eye Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dry Eye Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Dry Eye Drugs Segment by Company
Allergan
Novartis AG
Bausch Health
Santen Pharma
Takeda
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Dry Eye Drugs Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Other
Dry Eye Drugs Segment by Application
Hospital
Drug Stores
Online Pharmacies
Dry Eye Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Eye Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Eye Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Eye Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Anti-inflammatory Drugs
- Other
Applications
- Hospital
- Drug Stores
- Online Pharmacies
Companies covered
- Allergan
- Novartis AG
- Bausch Health
- Santen Pharma
- Takeda
- Johnson & Johnson
- United Laboratories
- Senju Pharmaceutical
- Jianfeng Group
- Eusan GMBH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dry Eye Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Dry Eye Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Dry Eye Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Dry Eye Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Dry Eye Drugs Market Dynamics
- 2.1 Dry Eye Drugs Industry Trends
- 2.2 Dry Eye Drugs Industry Drivers
- 2.3 Dry Eye Drugs Industry Opportunities and Challenges
- 2.4 Dry Eye Drugs Industry Restraints
3 Dry Eye Drugs Market by Manufacturers
- 3.1 Global Dry Eye Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Dry Eye Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Dry Eye Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Dry Eye Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dry Eye Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dry Eye Drugs Manufacturers, Product Type & Application
- 3.7 Global Dry Eye Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dry Eye Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dry Eye Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Dry Eye Drugs Tier 1, Tier 2, and Tier 3
4 Dry Eye Drugs Market by Type
- 4.1 Dry Eye Drugs Type Introduction
- 4.1.1 Artificial Tears
- 4.1.2 Anti-inflammatory Drugs
- 4.1.3 Other
- 4.2 Global Dry Eye Drugs Sales by Type
- 4.2.1 Global Dry Eye Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dry Eye Drugs Sales by Type (2021-2032)
- 4.2.3 Global Dry Eye Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Dry Eye Drugs Revenue by Type
- 4.3.1 Global Dry Eye Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dry Eye Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Dry Eye Drugs Revenue Market Share by Type (2021-2032)
5 Dry Eye Drugs Market by Application
- 5.1 Dry Eye Drugs Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Stores
- 5.1.3 Online Pharmacies
- 5.2 Global Dry Eye Drugs Sales by Application
- 5.2.1 Global Dry Eye Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dry Eye Drugs Sales by Application (2021-2032)
- 5.2.3 Global Dry Eye Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Dry Eye Drugs Revenue by Application
- 5.3.1 Global Dry Eye Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dry Eye Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Dry Eye Drugs Revenue Market Share by Application (2021-2032)
6 Global Dry Eye Drugs Sales by Region
- 6.1 Global Dry Eye Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dry Eye Drugs Sales by Region (2021-2032)
- 6.2.1 Global Dry Eye Drugs Sales by Region (2021-2026)
- 6.2.2 Global Dry Eye Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Dry Eye Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Dry Eye Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dry Eye Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Dry Eye Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dry Eye Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Dry Eye Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dry Eye Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Dry Eye Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Dry Eye Drugs Revenue by Region
- 7.1 Global Dry Eye Drugs Revenue by Region
- 7.1.1 Global Dry Eye Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Dry Eye Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Dry Eye Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Dry Eye Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Dry Eye Drugs Revenue (2021-2032)
- 7.2.2 North America Dry Eye Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Dry Eye Drugs Revenue (2021-2032)
- 7.3.2 Europe Dry Eye Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dry Eye Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Dry Eye Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dry Eye Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Dry Eye Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Allergan
- 8.1.1 Allergan Company Information
- 8.1.2 Allergan Business Overview
- 8.1.3 Allergan Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Allergan Dry Eye Drugs Product Portfolio
- 8.1.5 Allergan Recent Developments
- 8.2 Novartis AG
- 8.2.1 Novartis AG Company Information
- 8.2.2 Novartis AG Business Overview
- 8.2.3 Novartis AG Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis AG Dry Eye Drugs Product Portfolio
- 8.2.5 Novartis AG Recent Developments
- 8.3 Bausch Health
- 8.3.1 Bausch Health Company Information
- 8.3.2 Bausch Health Business Overview
- 8.3.3 Bausch Health Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bausch Health Dry Eye Drugs Product Portfolio
- 8.3.5 Bausch Health Recent Developments
- 8.4 Santen Pharma
- 8.4.1 Santen Pharma Company Information
- 8.4.2 Santen Pharma Business Overview
- 8.4.3 Santen Pharma Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Santen Pharma Dry Eye Drugs Product Portfolio
- 8.4.5 Santen Pharma Recent Developments
- 8.5 Takeda
- 8.5.1 Takeda Company Information
- 8.5.2 Takeda Business Overview
- 8.5.3 Takeda Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Takeda Dry Eye Drugs Product Portfolio
- 8.5.5 Takeda Recent Developments
- 8.6 Johnson & Johnson
- 8.6.1 Johnson & Johnson Company Information
- 8.6.2 Johnson & Johnson Business Overview
- 8.6.3 Johnson & Johnson Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Johnson & Johnson Dry Eye Drugs Product Portfolio
- 8.6.5 Johnson & Johnson Recent Developments
- 8.7 United Laboratories
- 8.7.1 United Laboratories Company Information
- 8.7.2 United Laboratories Business Overview
- 8.7.3 United Laboratories Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 United Laboratories Dry Eye Drugs Product Portfolio
- 8.7.5 United Laboratories Recent Developments
- 8.8 Senju Pharmaceutical
- 8.8.1 Senju Pharmaceutical Company Information
- 8.8.2 Senju Pharmaceutical Business Overview
- 8.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Senju Pharmaceutical Dry Eye Drugs Product Portfolio
- 8.8.5 Senju Pharmaceutical Recent Developments
- 8.9 Jianfeng Group
- 8.9.1 Jianfeng Group Company Information
- 8.9.2 Jianfeng Group Business Overview
- 8.9.3 Jianfeng Group Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jianfeng Group Dry Eye Drugs Product Portfolio
- 8.9.5 Jianfeng Group Recent Developments
- 8.10 Eusan GMBH
- 8.10.1 Eusan GMBH Company Information
- 8.10.2 Eusan GMBH Business Overview
- 8.10.3 Eusan GMBH Dry Eye Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Eusan GMBH Dry Eye Drugs Product Portfolio
- 8.10.5 Eusan GMBH Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dry Eye Drugs Value Chain Analysis
- 9.1.1 Dry Eye Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dry Eye Drugs Production Mode & Process
- 9.2 Dry Eye Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dry Eye Drugs Distributors
- 9.2.3 Dry Eye Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst